Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Afschin Gandjour

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Health Economics, Policy, and Law|January 7, 2025
Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysisAfschin Gandjour
BMC Health Services Research|November 28, 2024
Modelling the cost-effectiveness and budget impact of pay-for-performance programs in health careAfschin Gandjour
The Quarterly Review of Economics and Finance : Journal of the Midwest Economics Association|October 19, 2020
The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in GermanyAfschin Gandjour
BMC Health Services Research|December 13, 2021
The price of curing cancerAfschin Gandjour
BMC Health Services Research|November 10, 2021
A parsimonious model to validate cost-effectiveness analyses on preventive health careAfschin Gandjour
BMC Health Services Research|January 10, 2022
Benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer's perspectiveAfschin Gandjour
The Quarterly Review of Economics and Finance : Journal of the Midwest Economics Association|January 3, 2022
Value-based pricing of a COVID-19 vaccineAfschin Gandjour
Plos One|September 2, 2025
A quantitative projection of the net health effects of cannabis legalization in GermanyAfschin Gandjour
BMC Health Services Research|December 17, 2022
COVID-19 and the forgone health benefits of elective operationsAfschin Gandjour
Pharmacoeconomics|May 4, 2011
Prioritizing comparative effectiveness research: are drug and implementation trials equally worth funding?Afschin Gandjour
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Health Economics, Policy, and Law|January 7, 2025
Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysisAfschin Gandjour
BMC Health Services Research|November 28, 2024
Modelling the cost-effectiveness and budget impact of pay-for-performance programs in health careAfschin Gandjour
The Quarterly Review of Economics and Finance : Journal of the Midwest Economics Association|October 19, 2020
The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in GermanyAfschin Gandjour
BMC Health Services Research|December 13, 2021
The price of curing cancerAfschin Gandjour
BMC Health Services Research|November 10, 2021
A parsimonious model to validate cost-effectiveness analyses on preventive health careAfschin Gandjour
BMC Health Services Research|January 10, 2022
Benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer's perspectiveAfschin Gandjour
The Quarterly Review of Economics and Finance : Journal of the Midwest Economics Association|January 3, 2022
Value-based pricing of a COVID-19 vaccineAfschin Gandjour
Plos One|September 2, 2025
A quantitative projection of the net health effects of cannabis legalization in GermanyAfschin Gandjour
BMC Health Services Research|December 17, 2022
COVID-19 and the forgone health benefits of elective operationsAfschin Gandjour
Pharmacoeconomics|May 4, 2011
Prioritizing comparative effectiveness research: are drug and implementation trials equally worth funding?Afschin Gandjour
Pageof 12